Introduction: Skin cancer is one of the most prevalent malignancies worldwide, with incidence increasing by approximately 2–3% annually due to prolonged ultraviolet radiation exposure, genetic predisposition, and an ageing population. Conventional treatments, including oral, injectable, and topical therapies, are often...
Bhupendra G. Prajapati, O. Alsaidan, Sami I. Alzarea et al.· BioImpacts· 0 citations
The key challenges to GBM therapy are summarized and folate-decorated nanotheranostics, via tailored chemistry and increased tumoral contact, constitute a potential option for GBM precision therapy.
Dipak B. Bari, C. Pardeshi· Medical Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.